Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOREPEN LABS Gains 13%; BSE HEALTHCARE Index Up 0.2%
Thu, 22 Aug 14:13

MOREPEN LABS Gains 13%; BSE HEALTHCARE Index Up 0.2%Image source: Sakorn BernardaSv/www.istockphoto.com

MOREPEN LABS share price has zoomed 13% and is presently trading at Rs 78.3.

Meanwhile, the BSE HEALTHCARE index is at 42,085.2 (up 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are AARTI DRUGS (up 7.6%) and Natco Pharma (up 5.1%).

GSK Pharma (down 4.3%) and Procter & Gamble Health (down 2.6%) are among the top losers today.

Over the last one year, MOREPEN LABS has moved up from Rs 37.1 to Rs 78.3, registering a gain of Rs 41.3 (up 111.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 42,085.2, registering a gain of 50.2% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 130.0%), Glenmark Pharma (up 116.4%) and GSK Pharma (up 108.8%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,070.5 (up 0.2%).

The top gainers among the BSE Sensex today are Bharti Airtel (up 1.7%) and Tata Steel (up 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and Bharti Airtel.

In the meantime, NSE Nifty is at 24,826.3 (up 0.2%). Grasim Industries and Tata Consumer Products are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 81,070.5, registering a gain of 15,854.4 points (up 24.3%).

MOREPEN LABS Financial Update...

MOREPEN LABS net profit grew 147.2% YoY to Rs 362 million for the quarter ended June 2024, compared to a profit of Rs 146 million a year ago. Net sales rose 13.5% to Rs 4,552 million during the period as against Rs 4,010 million in April-June 2023.

For the year ended March 2023, MOREPEN LABS reported 62.0% decrease in net profit to Rs 387 million compared to net profit of Rs 1,017 million during FY22. Revenue of the company fell 8.4% to Rs 14,175 million during FY23.

The current Price to earnings ratio of MOREPEN LABS, based on rolling 12 month earnings, stands at 36.3.


Equitymaster requests your view! Post a comment on "MOREPEN LABS Gains 13%; BSE HEALTHCARE Index Up 0.2%". Click here!